Phathom Pharmaceuticals 10K Form
7 Day Trial
ALL ACCESS PASS
10K form not available
Receive PHAT News And Ratings
See the #1 stock for the next 7 days that we like better than PHAT
PHAT Financial Statistics
Sales & Book Value
|Price / Cash Flow:||0|
|Price / Book:||0|
|Net Income (TTM):||$-197.72M|
|Return on Equity:||0%|
|Return on Assets:||0%|
Phathom Pharmaceuticals Earnings Forecast
Key Phathom Pharmaceuticals Financial Ratios
- The Interest Expense is -13.81% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Phathom Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
|Trailing P/E Ratio:||0|
|Forward P/E Ratio:||0|
PHAT Technical Analysis vs Fundamental Analysis
Phathom Pharmaceuticals (PHAT) is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $7.14. The Score for PHAT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.